Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fibrogen Inc CS (FGEN)

Fibrogen Inc CS (FGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments

/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...

RHHBY : 34.6700 (+0.43%)
ONCY : 1.0200 (-0.97%)
VSTM : 3.47 (-5.19%)
CADL : 7.29 (-3.32%)
FGEN : 1.1200 (-3.45%)
REGN : 1,036.52 (+0.97%)
ONC.TO : 1.40 (unch)
The Fight Against Pancreatic Cancer: Biotech Firms Develop New Solutions for Rising Gen X Cases

USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita...

ONCY : 1.0200 (-0.97%)
ONC.TO : 1.40 (unch)
RHHBY : 34.6700 (+0.43%)
VSTM : 3.47 (-5.19%)
CADL : 7.29 (-3.32%)
FGEN : 1.1200 (-3.45%)
REGN : 1,036.52 (+0.97%)
Stock Index Futures Slip on Growth Fears, U.S. JOLTs Report in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.36%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.34% this morning after weak manufacturing data raised concerns about the U.S. economic health,...

ESM24 : 5,437.50s (-0.02%)
NQM24 : 19,685.50s (+0.42%)
PARA : 10.17 (-1.74%)
NVDA : 131.88 (+1.75%)
BA : 177.27 (-1.90%)
SAIC : 113.50 (-1.36%)
FANG : 185.97 (-2.30%)
DVN : 45.56 (+0.33%)
CRWD : 385.43 (+0.69%)
FERG : 201.47 (-2.95%)
PVH : 113.26 (+0.04%)
HPE : 21.60 (-0.74%)
Biotech Innovations Drive Pancreatic Cancer Treatment: Market Expected to Reach $7.4 Billion by 2032

USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by focusing on earlier detection. According to Johns Hopkins...

ONCY : 1.0200 (-0.97%)
ONC.TO : 1.40 (unch)
VSTM : 3.47 (-5.19%)
CTMX : 1.3800 (-5.48%)
BNTX : 92.08 (-4.08%)
FGEN : 1.1200 (-3.45%)
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates

/CNW/ -- USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by...

ONCY : 1.0200 (-0.97%)
VSTM : 3.47 (-5.19%)
CTMX : 1.3800 (-5.48%)
BNTX : 92.08 (-4.08%)
FGEN : 1.1200 (-3.45%)
ONC.TO : 1.40 (unch)
FibroGen: Q1 Earnings Snapshot

FibroGen: Q1 Earnings Snapshot

FGEN : 1.1200 (-3.45%)
FibroGen: Q3 Earnings Snapshot

FibroGen: Q3 Earnings Snapshot

FGEN : 1.1200 (-3.45%)
Stocks Move Higher Before the Open as Investors Await Key U.S. GDP Data, Salesforce Earnings on Tap

September S&P 500 futures (ESU23) are up +0.06%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.07% this morning after three major U.S. benchmark indices rallied on Tuesday as soft economic...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
CTLT : 55.48 (-0.88%)
PDD : 148.98 (-1.38%)
VZ : 39.67 (-0.28%)
T : 17.64 (-0.17%)
CRM : 231.94 (+1.27%)
CRWD : 385.43 (+0.69%)
CHWY : 22.14 (-4.77%)
ORSTE.C.DX : 387.750 (-1.66%)
PRU.LN : 700.000 (-1.07%)
HPQ : 35.51 (-2.58%)
FibroGen: Q2 Earnings Snapshot

FibroGen: Q2 Earnings Snapshot

FGEN : 1.1200 (-3.45%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN). Such investors are...

FGEN : 1.1200 (-3.45%)

Barchart Exclusives

Up 27% YTD, How Much Higher Can This Small-Cap Clean Energy Stock Rise?
SolarBank is a small-cap clean energy company that has outpaced the broader markets in 2024. Is SUUN stock a good buy right now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar